Impact Stories in Gastroenterology

Driving your impact story and inspiring real change

Impact stories from our gastroenterology journals

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Gut

Journal:

Yun Kit Yeoh, Tao Zuo, Grace Chung-Yan Lui, Fen Zhang, Qin Liu, Amy YL Li, Arthur CK Chung, Chun Pan Cheung, Eugene YK Tso, Kitty SC Fung, Veronica Chan, Lowell Ling, Gavin Joynt, David Shu-Cheong Hui, Kai Ming Chow, Susanna So Shan Ng, Timothy Chun-Man Li, Rita WY Ng, Terry CF Yip, Grace Lai-Hung Wong, Francis KL Chan, Chun Kwok Wong, Paul KS Chan and Siew C Ng January 2021

Authors:

Publication date:

This article has received 850 academic citations, and had 8 citations in Policy Documents and Clinical Guidelines. See the full details below.

Real world impact

Cited:

Top sources

in 8 documents (5 Health Policy; 3 Clinical Guidelines) from 6 countries with 7 different sources

Citation source

No. Citations

Citing country EU Belgium Canada Intergovernmental Organization (IGO) Spain UK Citing country Citing policy and guidance countries

BMJ Impact Analytics April 2024

Academic impact

Altmetric April 2024 and Dimensions April 2024

Let’s hear from Siew C. Ng, Chinese University of Hong Kong, about this 2021 article published in Gut

“Overall, open access publishing democratizes access to information, amplifies the reach and influence of research, and advances the collective pursuit of knowledge for the benefit of society.”

Professor Siew C. Ng is Assistant Dean (Development), and Croucher Professor in Medical Sciences at the Chinese University of Hong Kong.

What inspired you to pursue research in this particular area?

While clinical observation had hinted at COVID-19’s involvement with the gastrointestinal (GI) tract, our initial investigations further substantiated this by demonstrating the impact of the virus on the gut microbiome. However, there remained a critical knowledge gap regarding how these changes correlated with disease severity and resolution. Recognizing the potential clinical implications, including the refinement of treatment approaches and insights into lingering post-COVID-19 symptoms, we saw the importance of elucidating the role of the gut microbiome in the severity of COVID-19. Delving into the representation of specific microbiota in COVID-19 patients could offer valuable insights into the interplay between the microbiome and the host immune response during the disease, which will contribute to the understanding of COVID-19 pathophysiology beyond respiratory symptoms.

Read full article

How do you envision your research contributing to the broader field or addressing real-world issues? This study illuminated the role of the gut microbiome in COVID-19 severity, bridging a crucial gap in understanding beyond respiratory symptoms. By correlating changes in gut bacteria with disease severity and resolution, our findings may refine treatment strategies for COVID- 19 patients and provide insights into lingering post-COVID-19 symptoms. This work not only contributes to advancing scientific knowledge but also holds promise for informing personalized patient care and public health interventions. Ultimately, our findings may have far-reaching implications, ranging from improving individual patient outcomes to informing broader strategies for managing infectious diseases and enhancing overall public health resilience.

What motivated you to publish your work in an open access format?

Given the urgent and global nature of the COVID-19 pandemic, we were motivated to publish our work in an open access format to contribute to the collective efforts in addressing this pressing public health crisis. By making our findings freely available to researchers, healthcare professionals, policymakers, and the public, we aim to facilitate the rapid dissemination of crucial information that can inform evidence-based decision-making, guide effective interventions, and ultimately help alleviate the burden of COVID-19. Open access ensures that our research reaches a wide audience without barriers, allowing for widespread collaboration, innovation, and collective action in combating the pandemic. By embracing open access, we hope to maximize the impact of our work in advancing scientific understanding, improving patient outcomes, and contributing to global efforts to control and mitigate the effects of COVID-19.

What do you see as the benefits of open access publishing compared to traditional publishing models? Open access publishing offers numerous advantages over traditional models. By making research freely accessible to anyone with an internet connection, it fosters wider dissemination of knowledge, promotes collaboration, and enhances the visibility and impact of research findings. Additionally, open access promotes transparency and accountability in research, driving reproducibility and public trust in the scientific process. Overall, open access publishing democratizes access to information, amplifies the reach and influence of research, and advances the collective pursuit of knowledge for the benefit of society. What advice would you give to other researchers who are considering publishing their work in open access formats for the first time? I recommend understanding different models, selecting reputable journals, and exploring funding options. Familiarize yourself with licensing policies, promote your research for broader engagement, and monitor its impact. Open access publishing offers increased visibility, accessibility, and potential for collaboration, but it’s crucial to navigate the process strategically to maximize the reach and impact of your work while ensuring alignment with your goals, preferences and funding.

Read full article

“Overall, open access publishing democratizes access to information, amplifies the reach and influence of research, and advances the collective pursuit of knowledge for the benefit of society” Professor Siew C. Ng Chinese University of Hong Kong

Explore our range of journals in gastroenterology

Start your publishing journey with us

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7

bmjgroup.com

Powered by